82 related articles for article (PubMed ID: 20534349)
21. Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes.
Henry SD; van der Wegen P; Metselaar HJ; Tilanus HW; Scholte BJ; van der Laan LJ
Mol Ther; 2006 Oct; 14(4):485-93. PubMed ID: 16872906
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of intracellular trans-splicing ribozyme activity against hepatitis C virus internal ribosome entry site.
Ryu KJ; Lee SW
J Microbiol; 2004 Dec; 42(4):361-4. PubMed ID: 15650696
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of hepatitis B virus replication by shRNAs in stably HBV expressed HEPG2 2.2.15 cell lines.
Kayhan H; Karatayli E; Turkyilmaz AR; Sahin F; Yurdaydin C; Bozdayi AM
Arch Virol; 2007; 152(5):871-9. PubMed ID: 17245534
[TBL] [Abstract][Full Text] [Related]
24. Designing optimal siRNA based on target site accessibility.
Hofacker IL; Tafer H
Methods Mol Biol; 2010; 623():137-54. PubMed ID: 20217549
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of hepatitis C virus replication and expression by small interfering RNA targeting host cellular genes.
Xue Q; Ding H; Liu M; Zhao P; Gao J; Ren H; Liu Y; Qi ZT
Arch Virol; 2007; 152(5):955-62. PubMed ID: 17273891
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic targeting of HCV internal ribosomal entry site RNA.
Davis DR; Seth PP
Antivir Chem Chemother; 2011; 21(3):117-28. PubMed ID: 21233533
[TBL] [Abstract][Full Text] [Related]
27. A cellular protein specifically binds to the 3'-terminal sequences of hepatitis C virus intermediate negative-strand RNA.
Wang W; Deng Q; Huang K; Duan Z; Shao J; Huang Z; Huang Z
Chin Med J (Engl); 2003 Jun; 116(6):932-6. PubMed ID: 12877810
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot.
Moon JS; Lee SH; Kim EJ; Cho H; Lee W; Kim GW; Park HJ; Cho SW; Lee C; Oh JW
PLoS One; 2016; 11(1):e0146710. PubMed ID: 26751678
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of hepatitis C virus infection in cell culture by small interfering RNAs.
Chevalier C; Saulnier A; Benureau Y; Fléchet D; Delgrange D; Colbère-Garapin F; Wychowski C; Martin A
Mol Ther; 2007 Aug; 15(8):1452-62. PubMed ID: 17505476
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs.
Yokota T; Sakamoto N; Enomoto N; Tanabe Y; Miyagishi M; Maekawa S; Yi L; Kurosaki M; Taira K; Watanabe M; Mizusawa H
EMBO Rep; 2003 Jun; 4(6):602-8. PubMed ID: 12740604
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of HCV replication by small interfering RNA.
Ray RB; Kanda T
Methods Mol Biol; 2009; 510():251-62. PubMed ID: 19009267
[TBL] [Abstract][Full Text] [Related]
32. The anti-genomic (negative) strand of Hepatitis C Virus is not targetable by shRNA.
Lisowski L; Elazar M; Chu K; Glenn JS; Kay MA
Nucleic Acids Res; 2013 Apr; 41(6):3688-98. PubMed ID: 23396439
[TBL] [Abstract][Full Text] [Related]
33. Secondary structure and hybridization accessibility of hepatitis C virus 3'-terminal sequences.
Smith RM; Walton CM; Wu CH; Wu GY
J Virol; 2002 Oct; 76(19):9563-74. PubMed ID: 12208936
[TBL] [Abstract][Full Text] [Related]
34. Silencing of hepatitis A virus infection by small interfering RNAs.
Kusov Y; Kanda T; Palmenberg A; Sgro JY; Gauss-Müller V
J Virol; 2006 Jun; 80(11):5599-610. PubMed ID: 16699041
[TBL] [Abstract][Full Text] [Related]
35. Prospects for nucleic acid-based therapeutics against hepatitis C virus.
Lee CH; Kim JH; Lee SW
World J Gastroenterol; 2013 Dec; 19(47):8949-62. PubMed ID: 24379620
[TBL] [Abstract][Full Text] [Related]
36. In vivo therapeutic potential of Dicer-hunting siRNAs targeting infectious hepatitis C virus.
Watanabe T; Hatakeyama H; Matsuda-Yasui C; Sato Y; Sudoh M; Takagi A; Hirata Y; Ohtsuki T; Arai M; Inoue K; Harashima H; Kohara M
Sci Rep; 2014 Apr; 4():4750. PubMed ID: 24756133
[TBL] [Abstract][Full Text] [Related]
37. The
Wan H; Adams RL; Lindenbach BD; Pyle AM
J Virol; 2022 Apr; 96(8):e0194621. PubMed ID: 35353000
[TBL] [Abstract][Full Text] [Related]
38. Structural analysis of hepatitis C RNA genome using DNA microarrays.
Martell M; Briones C; de Vicente A; Piron M; Esteban JI; Esteban R; Guardia J; Gómez J
Nucleic Acids Res; 2004; 32(11):e90. PubMed ID: 15247323
[TBL] [Abstract][Full Text] [Related]
39. Three properties of the hepatitis C virus RNA genome related to antiviral strategies based on RNA-therapeutics: variability, structural conformation and tRNA mimicry.
Gómez J; Nadal A; Sabariegos R; Beguiristain N; Martell M; Piron M
Curr Pharm Des; 2004; 10(30):3741-56. PubMed ID: 15579068
[TBL] [Abstract][Full Text] [Related]
40. The Coding Region of the HCV Genome Contains a Network of Regulatory RNA Structures.
Pirakitikulr N; Kohlway A; Lindenbach BD; Pyle AM
Mol Cell; 2016 Apr; 62(1):111-20. PubMed ID: 26924328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
